Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis
TP53 is the most frequently mutated gene in human cancer. While no TP53-targeting drugs have been approved in the USA or Europe so far, preclinical and clinical studies are underway to investigate targeting of specific or all TP53 mutations, for example, by restoration of the functionality of mutate...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
14 April 2023
|
| In: |
Cell death discovery
Year: 2023, Jahrgang: 9, Pages: 1-14 |
| ISSN: | 2058-7716 |
| DOI: | 10.1038/s41420-023-01413-1 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/s41420-023-01413-1 Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/s41420-023-01413-1 
|
| Verfasserangaben: | Eva Romanovsky, Klaus Kluck, Iordanis Ourailidis, Michael Menzel, Susanne Beck, Markus Ball, Daniel Kazdal, Petros Christopoulos, Peter Schirmacher, Thorsten Stiewe, Albrecht Stenzinger and Jan Budczies |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1870626338 | ||
| 003 | DE-627 | ||
| 005 | 20240307041421.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231120s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41420-023-01413-1 |2 doi | |
| 035 | |a (DE-627)1870626338 | ||
| 035 | |a (DE-599)KXP1870626338 | ||
| 035 | |a (OCoLC)1425209197 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Romanovsky, Eva |e VerfasserIn |0 (DE-588)1310450110 |0 (DE-627)1870627385 |4 aut | |
| 245 | 1 | 0 | |a Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis |c Eva Romanovsky, Klaus Kluck, Iordanis Ourailidis, Michael Menzel, Susanne Beck, Markus Ball, Daniel Kazdal, Petros Christopoulos, Peter Schirmacher, Thorsten Stiewe, Albrecht Stenzinger and Jan Budczies |
| 264 | 1 | |c 14 April 2023 | |
| 300 | |a 14 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 20.11.2023 | ||
| 520 | |a TP53 is the most frequently mutated gene in human cancer. While no TP53-targeting drugs have been approved in the USA or Europe so far, preclinical and clinical studies are underway to investigate targeting of specific or all TP53 mutations, for example, by restoration of the functionality of mutated TP53 (TP53mut) or protecting wildtype TP53 (TP53wt) from negative regulation. We performed a comprehensive mRNA expression analysis in 24 cancer types of TCGA to extract (i) a consensus expression signature shared across TP53 mutation types and cancer types, (ii) differential gene expression patterns between tumors harboring different TP53 mutation types such as loss of function, gain of function or dominant-negative mutations, and (iii) cancer-type-specific patterns of gene expression and immune infiltration. Analysis of mutational hotspots revealed both similarities across cancer types and cancer type-specific hotspots. Underlying ubiquitous and cancer type-specific mutational processes with the associated mutational signatures contributed to explaining this observation. Virtually no genes were differentially expressed between tumors harboring different TP53 mutation types, while hundreds of genes were over- and underexpressed in TP53mut compared to TP53wt tumors. A consensus list included 178 genes that were overexpressed and 32 genes that were underexpressed in the TP53mut tumors of at least 16 of the investigated 24 cancer types. In an association analysis of immune infiltration with TP53 mutations in 32 cancer subtypes, decreased immune infiltration was observed in six subtypes, increased infiltration in two subtypes, a mixed pattern of decreased and increased immune cell populations in four subtypes, while immune infiltration was not associated with TP53 status in 20 subtypes. The analysis of a large cohort of human tumors complements results from experimental studies and supports the view that TP53 mutations should be further evaluated as predictive markers for immunotherapy and targeted therapies. | ||
| 650 | 4 | |a Diagnostic markers | |
| 650 | 4 | |a Prognostic markers | |
| 700 | 1 | |a Kluck, Klaus |e VerfasserIn |0 (DE-588)122679940X |0 (DE-627)1747876127 |4 aut | |
| 700 | 1 | |a Ourailidis, Iordanis |e VerfasserIn |0 (DE-588)1262794714 |0 (DE-627)1810715458 |4 aut | |
| 700 | 1 | |a Menzel, Michael |e VerfasserIn |0 (DE-588)1247100944 |0 (DE-627)1780550677 |4 aut | |
| 700 | 1 | |a Beck, Susanne |d 1985- |e VerfasserIn |0 (DE-588)1164102362 |0 (DE-627)1028488866 |0 (DE-576)508378915 |4 aut | |
| 700 | 1 | |a Ball, Markus |e VerfasserIn |0 (DE-588)1057908746 |0 (DE-627)795401108 |0 (DE-576)41391738X |4 aut | |
| 700 | 1 | |a Kazdal, Daniel |d 1983- |e VerfasserIn |0 (DE-588)114929650X |0 (DE-627)1009614088 |0 (DE-576)496635867 |4 aut | |
| 700 | 1 | |a Christopoulos, Petros |d 1977- |e VerfasserIn |0 (DE-588)138659702 |0 (DE-627)604886756 |0 (DE-576)308488067 |4 aut | |
| 700 | 1 | |a Schirmacher, Peter |d 1961- |e VerfasserIn |0 (DE-588)1020440112 |0 (DE-627)691221197 |0 (DE-576)360427448 |4 aut | |
| 700 | 1 | |a Stiewe, Thorsten |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stenzinger, Albrecht |e VerfasserIn |0 (DE-588)139606106 |0 (DE-627)703395238 |0 (DE-576)312432755 |4 aut | |
| 700 | 1 | |a Budczies, Jan |d 1970- |e VerfasserIn |0 (DE-588)124086403 |0 (DE-627)706532724 |0 (DE-576)186167679 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cell death discovery |d London : Nature Publishing Group, 2015 |g 9(2023) vom: Apr., Artikel-ID 126, Seite 1-14 |h Online-Ressource |w (DE-627)843856351 |w (DE-600)2842546-7 |w (DE-576)453320880 |x 2058-7716 |7 nnas |a Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis |
| 773 | 1 | 8 | |g volume:9 |g year:2023 |g month:04 |g elocationid:126 |g pages:1-14 |g extent:14 |a Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41420-023-01413-1 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/s41420-023-01413-1 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20231120 | ||
| 993 | |a Article | ||
| 994 | |a 2023 | ||
| 998 | |g 124086403 |a Budczies, Jan |m 124086403:Budczies, Jan |d 910000 |d 912000 |e 910000PB124086403 |e 912000PB124086403 |k 0/910000/ |k 1/910000/912000/ |p 12 |y j | ||
| 998 | |g 139606106 |a Stenzinger, Albrecht |m 139606106:Stenzinger, Albrecht |d 910000 |d 912000 |e 910000PS139606106 |e 912000PS139606106 |k 0/910000/ |k 1/910000/912000/ |p 11 | ||
| 998 | |g 1020440112 |a Schirmacher, Peter |m 1020440112:Schirmacher, Peter |d 910000 |d 912000 |e 910000PS1020440112 |e 912000PS1020440112 |k 0/910000/ |k 1/910000/912000/ |p 9 | ||
| 998 | |g 138659702 |a Christopoulos, Petros |m 138659702:Christopoulos, Petros |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PC138659702 |e 950000PC138659702 |e 950900PC138659702 |e 50000PC138659702 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 8 | ||
| 998 | |g 114929650X |a Kazdal, Daniel |m 114929650X:Kazdal, Daniel |d 910000 |d 912000 |e 910000PK114929650X |e 912000PK114929650X |k 0/910000/ |k 1/910000/912000/ |p 7 | ||
| 998 | |g 1057908746 |a Ball, Markus |m 1057908746:Ball, Markus |d 910000 |d 912000 |e 910000PB1057908746 |e 912000PB1057908746 |k 0/910000/ |k 1/910000/912000/ |p 6 | ||
| 998 | |g 1164102362 |a Beck, Susanne |m 1164102362:Beck, Susanne |d 910000 |d 912000 |e 910000PB1164102362 |e 912000PB1164102362 |k 0/910000/ |k 1/910000/912000/ |p 5 | ||
| 998 | |g 1247100944 |a Menzel, Michael |m 1247100944:Menzel, Michael |d 910000 |d 912000 |e 910000PM1247100944 |e 912000PM1247100944 |k 0/910000/ |k 1/910000/912000/ |p 4 | ||
| 998 | |g 1262794714 |a Ourailidis, Iordanis |m 1262794714:Ourailidis, Iordanis |d 910000 |d 912000 |e 910000PO1262794714 |e 912000PO1262794714 |k 0/910000/ |k 1/910000/912000/ |p 3 | ||
| 998 | |g 122679940X |a Kluck, Klaus |m 122679940X:Kluck, Klaus |d 910000 |d 912000 |e 910000PK122679940X |e 912000PK122679940X |k 0/910000/ |k 1/910000/912000/ |p 2 | ||
| 998 | |g 1310450110 |a Romanovsky, Eva |m 1310450110:Romanovsky, Eva |d 910000 |d 912000 |e 910000PR1310450110 |e 912000PR1310450110 |k 0/910000/ |k 1/910000/912000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1870626338 |e 4413879740 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 20.11.2023"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"14 April 2023"}],"title":[{"title_sort":"Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis","title":"Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis"}],"person":[{"role":"aut","family":"Romanovsky","given":"Eva","display":"Romanovsky, Eva"},{"display":"Kluck, Klaus","given":"Klaus","family":"Kluck","role":"aut"},{"display":"Ourailidis, Iordanis","family":"Ourailidis","given":"Iordanis","role":"aut"},{"role":"aut","display":"Menzel, Michael","given":"Michael","family":"Menzel"},{"family":"Beck","given":"Susanne","display":"Beck, Susanne","role":"aut"},{"role":"aut","family":"Ball","given":"Markus","display":"Ball, Markus"},{"role":"aut","family":"Kazdal","given":"Daniel","display":"Kazdal, Daniel"},{"display":"Christopoulos, Petros","family":"Christopoulos","given":"Petros","role":"aut"},{"family":"Schirmacher","given":"Peter","display":"Schirmacher, Peter","role":"aut"},{"role":"aut","given":"Thorsten","family":"Stiewe","display":"Stiewe, Thorsten"},{"display":"Stenzinger, Albrecht","given":"Albrecht","family":"Stenzinger","role":"aut"},{"family":"Budczies","given":"Jan","display":"Budczies, Jan","role":"aut"}],"language":["eng"],"physDesc":[{"extent":"14 S."}],"name":{"displayForm":["Eva Romanovsky, Klaus Kluck, Iordanis Ourailidis, Michael Menzel, Susanne Beck, Markus Ball, Daniel Kazdal, Petros Christopoulos, Peter Schirmacher, Thorsten Stiewe, Albrecht Stenzinger and Jan Budczies"]},"relHost":[{"pubHistory":["1 (2015)-"],"title":[{"title_sort":"Cell death discovery","title":"Cell death discovery"}],"origin":[{"publisherPlace":"London","dateIssuedDisp":"July 2015-","publisher":"Nature Publishing Group"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 19. September 2016"],"id":{"zdb":["2842546-7"],"issn":["2058-7716"],"eki":["843856351"]},"recId":"843856351","name":{"displayForm":["Cell Death Differentiation Association"]},"part":{"volume":"9","pages":"1-14","extent":"14","year":"2023","text":"9(2023) vom: Apr., Artikel-ID 126, Seite 1-14"},"physDesc":[{"extent":"Online-Ressource"}],"disp":"Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysisCell death discovery","language":["eng"]}],"id":{"eki":["1870626338"],"doi":["10.1038/s41420-023-01413-1"]},"recId":"1870626338"} | ||
| SRT | |a ROMANOVSKYHOMOGENOUS1420 | ||